A Methodological Review of US Budget-Impact Models for New Drugs.
about
Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework.The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges.Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
P2860
A Methodological Review of US Budget-Impact Models for New Drugs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Methodological Review of US Budget-Impact Models for New Drugs.
@en
type
label
A Methodological Review of US Budget-Impact Models for New Drugs.
@en
prefLabel
A Methodological Review of US Budget-Impact Models for New Drugs.
@en
P2860
P1433
P1476
A Methodological Review of US Budget-Impact Models for New Drugs.
@en
P2093
Josephine Mauskopf
Stephanie Earnshaw
P2860
P2888
P304
P356
10.1007/S40273-016-0426-8
P577
2016-06-22T00:00:00Z